D Harding-Larsen, J Funk, NG Madsen… - Biotechnology …, 2024 - Elsevier
Enzymes offer a more environmentally friendly and low-impact solution to conventional chemistry, but they often require additional engineering for their application in industrial …
M Wójcikowski, M Kukiełka… - …, 2019 - academic.oup.com
Abstract Motivation Fingerprints (FPs) are the most common small molecule representation in cheminformatics. There are a wide variety of FPs, and the Extended Connectivity …
S Jastrzebski, M Szymczak, A Pocha… - Journal of Chemical …, 2020 - ACS Publications
Docking is one of the most important steps in virtual screening pipelines, and it is an established method for examining potential interactions between ligands and receptors …
Structural fingerprints and pharmacophore modeling are methodologies that have been used for at least 2 decades in various fields of cheminformatics, from similarity searching to …
M Tutone, AM Almerico - European Journal of Medicinal Chemistry, 2017 - Elsevier
The cyclin dependent kinases (CDKs) are a small family of serine/threonine protein kinases that can act as a potential therapeutic target in several proliferative diseases, including …
Targeted polypharmacology of kinases has emerged as a promising strategy to design efficient and safe therapeutics. Here, we perform a systematic study of kinase–ligand …
B Zou, VHF Lee, H Yan - BMC bioinformatics, 2018 - Springer
Background Non-small cell lung cancer (NSCLC) with activating EGFR mutations, especially exon 19 deletions and the L858R point mutation, is particularly responsive to gefitinib and …
T Qin, Z Zhu, XS Wang, J Xia, S Wu - Expert Opinion on Drug …, 2021 - Taylor & Francis
Introduction: Structure-based virtual screening (SBVS) is an essential strategy for hit identification. SBVS primarily uses molecular docking, which exploits the protein–ligand …
EV Koroleva, ZI Ignatovich, YV Sinyutich… - Russian Journal of …, 2016 - Springer
The review compiles the strategies and methods of development of aminopyrimidine derivatives as targeted antitumor pharmaceuticals. The advances in organic and …